One of the goals of the International Myeloma Society is to foster research, clinical, basic science and translational research, that will advance the field and improve the outcomes for our patients. Through its awards, IMS aims to recognize the contribution of individuals who have made significant contributions to the field as well as upcoming investigators whose early works holds great promise.
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide. The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.